Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Prehab Prior to Stem Cell Transplantation in Multiple Myeloma
ClinicalTrials.gov study NCT06280924. IPD Sharing: YES. Countries: 1. Publications: 0.
Multiple Myeloma is a Hematologic Malignancy Characterized by the Accumulation of Malignant Plasma Cells in the Bone Marrow. Despite Advances in Treatment, Many Patients Experience Disease Relapse. Bi
ClinicalTrials.gov study NCT06888856. IPD Sharing: NO. Countries: 0. Publications: 0.
Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07359014. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy
ClinicalTrials.gov study NCT03785184. IPD Sharing: YES. Countries: 4. Publications: 0.
Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma
ClinicalTrials.gov study NCT00477815. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07030517. IPD Sharing: YES. Countries: 1. Publications: 0.
Combination Bortezomib-containing Regimens in Newly Diagnosed Patients With t (4; 14) Positive Multiple Myeloma
ClinicalTrials.gov study NCT00570180. IPD Sharing: NO. Countries: 1. Publications: 0.
Anlotinib Hydrochloride Capsule Monotherapy and Combination Therapy Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05549973. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Humanized Anti-CS1 Monoclonal IgG1 Antibody) and Bortezomib in Subjects With Multiple Myeloma Following One to Three Prior Th
ClinicalTrials.gov study NCT00726869. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Peginterferon α-2b as a Maintenance Therapy in Participants With Multiple Myeloma Who Responded to Induction Therapy (P01972-AM7)
ClinicalTrials.gov study NCT00732641. IPD Sharing: YES. Countries: 0. Publications: 0.
A Study of Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death Receptor-1 (PD-1) Inhibitor for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05338775. IPD Sharing: YES. Countries: 4. Publications: 0.
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
ClinicalTrials.gov study NCT07227311. IPD Sharing: YES. Countries: 0. Publications: 0.
Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00882063. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sorafenib in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00253578. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant
ClinicalTrials.gov study NCT01264315. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT03346135. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04640779. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prehabilitation With Aerobic and Resistance Exercise for Improving Physical Fitness and Quality of Life Outcomes in Older Patients Undergoing CAR-T Therapy for Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07045727. IPD Sharing: NO. Countries: 1. Publications: 0.
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
ClinicalTrials.gov study NCT06057402. IPD Sharing: NO. Countries: 5. Publications: 0.
Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer
ClinicalTrials.gov study NCT00006019. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.